Lupin Ltd KYS Report: Ownership & Insights | Research 360

15:24 Jan 28

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2131.10

-19.40 (-0.90%)

NSE BSE

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:24 Jan 28

2131.10

-19.40 (-0.90%)

68/100 High Financial Strength

Quality

42/100 Mid Valuation

Valuation

58/100 Technically Neutral

Technical

SWOT

Strength

15

Weakness

3

Opportunity

1

Threat

1

97.35K

Market Cap (Cr)

22.51

PE Ratio

5.00

Price to Book Ratio

52.53

RSI

14.45 %

Net Profit Margin

SWOT

Strength Weakness Opportunity Threats

Download Our App On:

Back

Back

Back

Back

OTP sent to your mobile number. Please enter it below to verify.

59 s

Verify Email OTP

OTP sent to

Didn’t receive a code? Don’t worry Retry in 59 s

Dear User,
please complete your profile!

Email ID Already Exists

Location Saved Successfully

Email Id Verified Successfully

Complete 2 steps process within few minutes

Step 2

OR

Enter OTP Sent on Your

59 s

Back

59 s

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password